Solvo Biotechnology's Acquisition

Solvo Biotechnology was acquired by CiToxLAB on March 12, 2018.

Solvo Biotechnology is a contract research organization specializing in drug transporter studies and the assessment of Drug-Drug Interactions. Solvo generates reports for submission to FDA/EMA.…

Articles about Solvo Biotechnology's Acquisition: